Munich-based AI startup, Aily Labs, has announced a €19m investment led by Insight Partners. Notably, this is the company’s first external funding since its inception in 2020. Unlike some of its contemporaries, which raise vast sums within mere months of their founding, Aily Labs has been profitable since its debut year. The funds will be channelled towards expanding its 200-strong team.
The inner workings of Aily Labs
Aily Labs specialises in deploying AI models that drive productivity, savings, and efficiency. Their core clientele includes top-tier pharmaceutical companies, with French multinational Sanofi mentioned prominently.
The startup’s primary product is a mobile-first AI decision intelligence app. It offers users a 360° view of enterprise data and harnesses advanced AI/ML techniques. This ensures real-time insights are readily available, aiding instantaneous and well-informed decision-making. Bianca Anghelina, CEO and founder of Aily Labs, emphasised the app’s transformative potential, noting its rapid integration capabilities.
Hilary Gosher, Managing Director at Insight Partners, lauded Aily Labs’ innovative approach. She believes the platform will set the benchmark for future decision-making processes in businesses.
Collaboration with global healthcare company, Sanofi
Aily Labs has gained traction with Sanofi using their Aily app (internally branded as ‘plai’). This app offers a comprehensive view of all Sanofi business operations, aiding in digital transformation. Thanks to Aily’s AI-driven insights, Sanofi’s decision-makers, ranging from senior executives to on-ground operators, have improved their decision-making processes, enhancing various aspects of their business operations.
Bianca Anghelina noted the app’s significant benefits for Sanofi, including more efficient site selection for clinical trials and refined manufacturing processes.
Background of the creators
Both cofounders of Aily Labs hail from the pharmaceutical sector. Leveraging their networks, they successfully signed Sanofi as an initial client. Anghelina described their growth strategy as creating a product, evolving with it, and subsequently scaling the team.
AI’s evolving marketplace
2023 has witnessed a spike in startups keen on creating their business-centric AI, akin to “ChatGPT for your business.” However, Aily Labs stands apart, adopting diverse machine learning approaches in its tech stack, like classification and regression models. This strategy empowers features that predict varied business outcomes.
Anghelina explained the significance of their machine learning models, which facilitate real-time scenario simulations. Additionally, GenAI is employed to generate textual insights from data.
The road ahead
With fresh funds in tow, Aily Labs plans to strengthen its GenAI team and enhance use cases for text-intensive clients. They also aim to amass competitive intelligence on competitors from external sources. New hires will include machine learning engineers and prompt engineers.
Their future goals include diversifying their clientele, initially focusing on the broader life sciences sector, followed by data-rich corporates.
In an industry teeming with well-funded competitors, Aily Labs boasts three crucial advantages: trusted clientele, a proven product, and profitability. The company is well-positioned to make the most out of the current AI-friendly environment in Germany. The latter was boosted recently by the announcement of more investment into this space by the Germany government.
—
If you want your company to be a part of the AI revolution, you need the right people. Speak to PL Talents recruitment expert – we work with some of the top candidates in software and data.